+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mexiletine"

Critical Care Antiarrhythmic Drugs Market Report 2025 - Product Thumbnail Image

Critical Care Antiarrhythmic Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Mexiletine is a medication used to treat irregular heartbeats, also known as arrhythmias. It is a type of antiarrhythmic drug, which works by blocking sodium channels in the heart, thus slowing the heart rate and restoring a normal rhythm. Mexiletine is used to treat ventricular arrhythmias, such as ventricular tachycardia and ventricular fibrillation, as well as atrial arrhythmias, such as atrial fibrillation and atrial flutter. It is also used to treat certain types of pain, such as trigeminal neuralgia. Mexiletine is available in both oral and intravenous forms. The cardiovascular drugs market is a large and growing market, with Mexiletine being one of the many drugs used to treat arrhythmias. Mexiletine is a relatively safe and effective drug, and is widely used in the treatment of arrhythmias. It is also relatively inexpensive, making it an attractive option for many patients. Some companies in the Mexiletine market include Pfizer, Novartis, Sanofi, Merck, and GlaxoSmithKline. Show Less Read more